Literature DB >> 25152692

Early lens extraction compared to standard treatment in acute primary angle closure.

Dolly S Chang1, Eugenio Maul2, David Friedman2.   

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the efficacy as well as harms of early lens extraction versus standard treatment in patients with acute primary angle closure.

Entities:  

Year:  2012        PMID： 25152692      PMCID： PMC4139041          DOI： 10.1002/14651858.CD010220

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN： 1361-6137


  7 in total

1.  Acute primary angle-closure: long-term intraocular pressure outcome in Asian eyes.

Authors:  T Aung; L P Ang; S P Chan; P T Chew
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

2.  Rates of hospital admissions for primary angle closure glaucoma among Chinese, Malays, and Indians in Singapore.

Authors:  T Y Wong; P J Foster; S K Seah; P T Chew
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

3.  The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota.

Authors:  J C Erie; D O Hodge; D T Gray
Journal:  Arch Ophthalmol       Date:  1997-02

4.  Epidemiology of acute primary angle-closure glaucoma in the Hong Kong Chinese population: prospective study.

Authors:  J S Lai; D T Liu; C C Tham; R T Li; D S Lam
Journal:  Hong Kong Med J       Date:  2001-06       Impact factor: 2.227

5.  The incidence and seasonal variations of acute primary angle-closure glaucoma.

Authors:  M Ivanisević; M Erceg; A Smoljanović; Z Trosić
Journal:  Coll Antropol       Date:  2002-06

6.  Incidence of acute primary angle-closure glaucoma in Singapore. An island-wide survey.

Authors:  S K Seah; P J Foster; P T Chew; A Jap; F Oen; H B Fam; A S Lim
Journal:  Arch Ophthalmol       Date:  1997-11

7.  Incidence of acute glaucoma in Finland from 1973 to 1982.

Authors:  J Teikari; I Raivio; M Nurminen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.